Evidence map›Paper›PMID 24660032›Full record

ArticleExperimental and therapeutic medicine2014

Effects of resveratrol on apoptosis in a rat model of vascular dementia.

Zhi-Kun Sun, Xing-Rong Ma, Yan-Jie Jia, Yan-Ru Liu, Jie-Wen Zhang, Bo-Ai Zhang

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhi-Kun SunDepartment of Neurology, Henan Provincial People's Hospital, Zhengzhou, Henan 450002, P.R. China.
Xing-Rong MaDepartment of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450002, P.R. China.
Yan-Jie JiaDepartment of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450002, P.R. China.
Yan-Ru LiuDepartment of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450002, P.R. China.
Jie-Wen ZhangDepartment of Neurology, Henan Provincial People's Hospital, Zhengzhou, Henan 450002, P.R. China.
Bo-Ai ZhangDepartment of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450002, P.R. China.
First Affiliated Hospital of Zhengzhou University · CNHenan Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol is a natural polyphenol widely present in plants, particularly in the skin of red grapes and in wine. It possesses a wide range of biological effects and exhibits neuroprotective effects in numerous diseases. However, data evaluating the effects of resveratrol in vascular dementia (VaD) are lacking. In the present study, the permanent, bilateral common carotid artery occlusion rat model was used to study the effects of resveratrol on VaD. The Morris water maze was used to test the spatial learning and memory performance of the rats. The expression levels of Bax, Bcl-2, cleaved caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in the hippocampus were measured. The results showed that resveratrol inhibited memory impairment in the VaD rat model, and attenuated the increases in the expression levels of Bax, cleaved caspase-3 and cleaved PARP and the reductions in the expression levels of Bcl-2 that were induced by VaD. These results provide a novel insight into the neuroprotective effects of resveratrol and its possible therapeutic role in VaD.

Indexed as

apoptosiscaspase-3poly(ADP-ribose) polymeraseresveratrolvascular dementia

Identifiers

PMID24660032
PMCPMC3961111
OpenAlexW1986000820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.